Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents
Y Wang, S Ma - ChemMedChem, 2013 - Wiley Online Library
Bacterial infections are a constant and serious threat to human health. With the increase of
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents
Y Wang, S Ma - ChemMedChem, 2013 - hero.epa.gov
Bacterial infections are a constant and serious threat to human health. With the increase of
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents
Y Wang, S Ma - ChemMedChem, 2013 - pubmed.ncbi.nlm.nih.gov
Bacterial infections are a constant and serious threat to human health. With the increase of
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.
Y Wang, S Ma - Chemmedchem, 2013 - europepmc.org
Bacterial infections are a constant and serious threat to human health. With the increase of
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …
multidrug resistance of clinically pathogenic bacteria, common antibiotic therapies have …